Photovoltaic living lab reaches the 100 Megawatt-hour mark

Blick auf die Solarfassade des Reallabors.

Blick auf die Solarfassade des Reallabors. © HZB

About three years ago, the living laboratory at HZB went into operation. Since then, the photovoltaic facade has been generating electricity from sunlight. On September 27, 2024, it reached the milestone of 100 megawatt-hours.

Solar facades offer untapped potential for generating clean electricity. How much they actually deliver and which environmental factors play a role are being studied at HZB's real laboratory. The facade elements installed there have now reached the 100-megawatt-hour mark.

This amount of energy is enough to supply a four-person household in Germany with clean electricity for 30 years. At HZB, the electricity generated by the laboratory’s solar facade is used entirely on-site, which makes the facility particularly economical. According to initial estimates, the additional costs compared to a conventional facade have amortized after 18 years.

What is the Living Lab?

It is a research building on the BESSY II location in Berlin-Adlershof equipped with a photovoltaic facade. A total of 360 frameless, blue-coated modules were installed on the south, west, and north facades of the building. Particular emphasis was placed on ensuring the solar facade elements are aesthetically pleasing.

The living laboratory is equipped with 120 sensors for measuring temperature, solar radiation, and wind flow. This allows the behavior of the solar modules and the entire PV facade system to be evaluated under different seasonal and weather conditions over a long period.

Findings contribute to the building-integrated photovoltaics advisory service

These insights directly contribute to advisory services, benefiting society as a whole. HZB operates the independent advisory service for building-integrated photovoltaics (BAIP). Experts provide advice to professionals in the construction industry on technologies, products, design options, technical feasibility, and legal frameworks.

 

sz

  • Copy link

You might also be interested in

  • Green hydrogen: MXenes shows talent as catalyst for oxygen evolution
    Science Highlight
    09.09.2024
    Green hydrogen: MXenes shows talent as catalyst for oxygen evolution
    The MXene class of materials has many talents. An international team led by HZB chemist Michelle Browne has now demonstrated that MXenes, properly functionalised, are excellent catalysts for the oxygen evolution reaction in electrolytic water splitting. They are more stable and efficient than the best metal oxide catalysts currently available. The team is now extensively characterising these MXene catalysts for water splitting at the Berlin X-ray source BESSY II and Soleil Synchrotron in France.
  • SpinMagIC: 'EPR on a chip' ensures quality of olive oil and beer
    News
    04.09.2024
    SpinMagIC: 'EPR on a chip' ensures quality of olive oil and beer
    The first sign of spoilage in many food products is the formation of free radicals, which reduces the shelf-life and the overall quality of the food. Until now, the detection of these molecules has been very costly for the food companies. Researchers at HZB and the University of Stuttgart have developed a portable, small and inexpensive 'EPR on a chip' sensor that can detect free radicals even at very low concentrations. They are now working to set up a spin-off company, supported by the EXIST research transfer programme of the German Federal Ministry of Economics and Climate Protection. The EPRoC sensor will initially be used in the production of olive oil and beer to ensure the quality of these products.
  • Review on ocular particle therapy (OPT) by international experts
    Science Highlight
    03.09.2024
    Review on ocular particle therapy (OPT) by international experts
    A team of leading experts in medical physics, physics and radiotherapy, including HZB physicist Prof. Andrea Denker and Charité medical physicist Dr Jens Heufelder, has published a review article on ocular particle therapy. The article appeared in the Red Journal, one of the most prestigious journals in the field. It outlines the special features of this form of eye therapy, explains the state of the art and current research priorities, provides recommendations for the delivery of radiotherapy and gives an outlook on future developments.